Jubilant Pharmova informs about deletion of tax demand raised on Jubilant Generics

10 Oct 2024 Evaluate
In reference to the Company’s disclosure dated July 27, 2024 filed under Regulation 30 of the SEBI Listing Regulations w.r.t. receipt of certain orders from the income tax department by Jubilant Generics (wholly owned step down Indian subsidiary), Jubilant Pharmova has informed that Jubilant Generics had preferred rectification application against certain tax demands raised by the Income Tax Department for Assessment Year 2020-21. Pursuant to rectification orders received, tax demand of Rs.38.13 crores stands deleted in its entirety. Information as required under Regulation 30 of the Listing Regulations read with Schedule III and the SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 with respect to receipt of an order from Income tax department in case of Jubilant Generics Limited is enclosed as Annexure A. The company has received the rectification order from the Income Tax Department at 05:59 pm (IST) on October 9, 2024.

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

1063.05 -29.15 (-2.67%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.